IVF: How Many Fertilized Eggs Make It to Blastocyst?

In a typical IVF cycle, roughly 40% to 60% of fertilized eggs develop into blastocysts by day five or six of culture. That range is wide because the conversion rate depends on the patient’s age, sperm quality, the lab’s culture conditions, and the underlying diagnosis driving treatment. Understanding where embryos drop off and why can help you set realistic expectations before a cycle begins.

What the Typical Numbers Look Like

Not every egg retrieved in an IVF cycle is usable, and each step from retrieval to blastocyst involves attrition. Of the eggs collected, about 70% to 80% are mature enough to fertilize. Of those that fertilize normally, somewhere around half will reach the blastocyst stage. One modeling study estimated that roughly 92% of fertilized eggs survive to cleavage stage (around day two or three), but only about 59% make it to blastocyst at age 35 and about 50% at age 40.¹ Studies of non-PCOS populations report blastocyst rates around 50% to 52%, while an optimized low-oxygen lab environment has pushed total blastocyst rates toward 55%.²

The big takeaway is that losing half your fertilized eggs by day five is normal, not a sign something went wrong. A woman who starts with ten fertilized eggs and ends up with four or five blastocysts is tracking with average outcomes. But averages obscure enormous individual variation, and the factors behind that variation matter.

Why Embryos Stop Developing

The first few days after fertilization are driven almost entirely by molecules the egg stored up before ovulation. The embryo essentially runs on the mother’s molecular toolkit until it switches on its own genes, an event researchers call embryonic genome activation. In humans, this happens around the eight-cell stage, roughly day three. The process involves the breakdown of the egg’s stored genetic instructions and the activation of thousands of new genes in the embryo itself.³

This handoff is a major bottleneck. If the embryo fails to activate its own genome properly, development stalls. Mutations in specific genes involved in this transition have been linked to early embryonic arrest, and disruptions to mitochondrial function and epigenetic reprogramming also play a role.⁴ In practice, this means many embryos that look fine on day two or three will arrest between days three and five when the embryo’s own genetic program takes over. The ones that clear this hurdle are the ones that reach blastocyst.

How Maternal Age Shifts the Numbers

Age is the single strongest predictor of how many fertilized eggs reach blastocyst. Research dating back decades has shown that in patients over 30, blastocyst development declines because more embryos arrest at the morula stage, the step just before blastocyst. Even among those that do reach blastocyst, the rate of expansion slows with increasing maternal age.⁵

The numbers tell a stark story. One study found a blastocyst development rate of about 40% in younger women compared to roughly 22% in women over 40.⁶ That is nearly cut in half. And even within the blastocysts that do form, older patients tend to have higher rates of chromosomal abnormalities, which reduces the number that are actually viable for transfer. So the age effect hits twice: fewer embryos make it to blastocyst, and fewer of the ones that arrive are chromosomally normal.

Sperm Quality Is Part of the Equation

Fertility conversations tend to focus on egg quality, but sperm contribute half the embryo’s DNA, and damage to that DNA affects blastocyst development. Sperm DNA fragmentation, a measure of how much the sperm’s genetic material is broken up, has a clear negative relationship with how many embryos reach blastocyst. One study found a moderate inverse correlation between fragmentation levels and blastocyst rates, with high fragmentation linked to lower blastocyst and pregnancy rates, even though fertilization itself was not affected.⁷

That last point is important. Sperm with significant DNA damage can still fertilize an egg, especially with ICSI (where sperm is injected directly). But the damage shows up downstream. A large study of over 870 ICSI cycles found that each percentage point increase in sperm DNA fragmentation reduced the odds of getting a top-quality blastocyst on day five by about 2.5%.⁸ Sperm shape also plays a role; when morphology was abnormal but DNA fragmentation was within normal range, blastocyst formation held up better than when both were off.⁹

What Happens in the Lab

Once eggs are fertilized, the embryology lab becomes the surrogate environment for the first five or six days of development. Two of the biggest controllable factors are the oxygen level in the incubator and the culture medium the embryos sit in.

Inside the body, embryos develop in very low oxygen, closer to 2% to 5% rather than the 20% found in room air. Labs that culture embryos at low oxygen consistently see better blastocyst rates. One randomized trial comparing low-oxygen (5%) with atmospheric-oxygen (about 19%) culture found the low-oxygen group had a blastocyst rate of about 48% versus 42%, along with a significantly higher birth rate.¹⁰ A more recent study testing a two-phase oxygen approach, dropping from 5% to 2% partway through culture, pushed the total blastocyst rate from about 44% up to roughly 55%, with the proportion of usable blastocysts climbing from around 22% to 33%.¹¹

Culture media, the nutrient solution embryos grow in, has been another long-running area of research. Some labs use a single medium throughout, while others switch formulations partway through (sequential media) to mimic the changing environment of the fallopian tube and uterus. Despite decades of debate, a meta-analysis found no meaningful difference in pregnancy rates between the two approaches.¹² A head-to-head comparison of two commercial media did find more high-quality early embryos in the single-medium group, but by the time you measured implantation and pregnancy rates, the difference disappeared.¹³ In short, oxygen level has a proven impact on blastocyst conversion, while the specific brand or type of culture medium matters less than you might think.

How PCOS and Diminished Ovarian Reserve Affect Blastocyst Rates

Polycystic ovary syndrome often produces a high number of eggs during stimulation, which can look like an advantage. But more eggs do not automatically mean more blastocysts. A study comparing PCOS and non-PCOS patients found blastocyst rates of about 45% and 52% respectively, a gap that was not statistically significant.² Within PCOS patients, menstrual regularity seems to matter. Women with PCOS who had regular cycles showed better downstream blastocyst development than those with irregular cycles, even though the irregular group had higher oocyte maturation rates.¹⁴

Diminished ovarian reserve presents the opposite situation: fewer eggs to start with. But the concern goes beyond quantity. Even after adjusting for age, women diagnosed with diminished ovarian reserve had about 24% lower odds of any given biopsied blastocyst being chromosomally normal compared to women without the diagnosis.¹⁵ That suggests a reduction in egg quality that goes hand in hand with the reduced egg count. Interestingly, when looking just at the per-embryo blastocyst conversion rate rather than chromosomal quality, one study found no significant differences between patients with diminished reserve and those with unexplained infertility when both used the same stimulation protocol.¹⁶ The embryos may reach blastocyst at similar rates, but fewer of them will be chromosomally viable.

Blastocyst Grading and What It Tells You

Not all blastocysts are equal. Embryologists grade them based on three features: how expanded the fluid-filled cavity is, the quality of the inner cell mass (the cluster of cells that becomes the baby), and the quality of the outer cell layer called the trophectoderm (which becomes the placenta). These grades, typically given as letters like AA, AB, or BC, carry real predictive weight.

In a large study of frozen-thawed single embryo transfers, live birth rates dropped steeply with inner cell mass grade: about 55% for grade A, 41% for grade B, and 28% for grade C. The outer cell layer mattered too, with grade C trophectoderm yielding a live birth rate of roughly 33% compared to about 53% for grade A.¹⁷ So while reaching blastocyst is a good sign, the grade at which an embryo arrives there still matters considerably for pregnancy chances.

Blastocyst morphology also correlates with chromosomal health. Higher expansion grades and better outer cell layer grades are associated with significantly higher chances of the embryo being chromosomally normal. In one cohort, the odds of a blastocyst being normal were roughly four and a half times higher with a grade A outer cell layer compared to grade C.¹⁸ The morphology is not a perfect proxy for genetic health, but it carries enough information that embryologists use it as a first-pass selection tool in clinics that do not perform genetic testing.

Developmental dynamics offer additional clues. Blastocysts that collapse and re-expand during their growth phase are more likely to be chromosomally abnormal, with the total time spent collapsed predicting lower odds of being euploid even after accounting for patient age and the embryo’s visual grade.¹⁹

The Trade-Off of Growing Embryos to Blastocyst

Growing embryos to blastocyst before transfer has clear advantages: it selects for embryos that have cleared the genome-activation bottleneck, and it improves synchronization with the uterine lining. A Cochrane review of 15 studies found that fresh blastocyst-stage transfers increased live birth rates compared to cleavage-stage transfers, with the odds improving by about 27%.²⁰

But extended culture comes with a risk that is often glossed over: the chance of having nothing to transfer. That same Cochrane review found the failure-to-transfer rate was about two and a half times higher in the blastocyst group. If you start with just one or two fertilized eggs, the odds that none survive to blastocyst become meaningful. A recent study of patients with a single fertilized egg found that cleavage-stage transfer actually led to a higher live birth rate per couple compared to waiting for blastocyst, with the advantage growing with age.¹ The reasoning is straightforward: a day-three embryo that arrests by day five in the lab might have survived to blastocyst inside the uterus, where conditions may be more favorable. Transferring early gives that embryo a chance the lab does not.

This is why many clinics tailor the decision to the individual cycle. Patients with many fertilized eggs benefit from extended culture because it helps the lab identify the strongest embryos for transfer. Patients with very few embryos may be better served by an earlier transfer rather than risking a total cycle loss in the dish.

How Stimulation Protocols Factor In

You might assume that different ovarian stimulation drugs or dosing schedules would meaningfully change blastocyst conversion rates, and the question comes up frequently in online forums. In practice, the effect appears small. A retrospective comparison of different controlled stimulation regimens found that top-quality blastocyst development rates were comparable, hovering around 37% to 43% regardless of the protocol used.²¹ Similarly, comparisons of patients with different ovarian reserve diagnoses on the same stimulation protocol show similar per-embryo blastocyst rates.¹⁶ The stimulation protocol mostly affects how many eggs you start with, not the per-egg odds of reaching blastocyst.

Artificial Intelligence in Embryo Assessment

One of the fastest-moving areas in IVF is the use of AI to predict which embryos will develop successfully and which will lead to a live birth. Traditional embryo grading is done by an embryologist looking through a microscope, and it is subjective. Two embryologists may grade the same blastocyst differently.

AI models trained on large image datasets are showing promising accuracy. One system analyzing day-three embryo images achieved an accuracy metric well above what is considered useful for clinical screening, and combining images from day one and day three improved performance further.²² A separate comparison between AI-based assessment and a traditional scoring system for predicting blastocyst implantation found the AI model had higher overall accuracy, about 73% versus 63%.²³

That said, the field is still catching up to its own hype. Time-lapse imaging systems, which take photos of embryos at regular intervals inside the incubator, generate enormous amounts of morphokinetic data. Algorithms built on this data have been used to create scoring systems for embryo selection, but their predictive power has been limited. A review noted that so far, no conclusive evidence shows these automated scoring systems outperform an experienced embryologist’s visual assessment on a large scale.²⁴ AI is improving faster than the older algorithm-based approaches, but it is not yet the default decision-maker in most clinics. It works best as a second opinion alongside human judgment rather than a replacement for it.

Add-On Therapies and Their Limits

Patients understandably search for anything that might boost their blastocyst numbers, and clinics sometimes offer supplements or adjunct therapies marketed for egg quality. Growth hormone supplementation for patients with diminished ovarian reserve is one of the more commonly discussed options. However, a comparative study found no significant difference in mean blastocysts per cycle between patients who received growth hormone and those who did not, and live birth rates per retrieval were virtually identical at about 28% in both groups.²⁵

Antioxidants like Coenzyme Q10 have generated interest as well, with some animal research showing improved blastocyst formation rates. But extrapolating from cow or mouse embryos to human IVF outcomes requires caution, and robust human trial data on most supplements remains thin. The evidence is strongest for the factors already discussed: age, sperm quality, and lab oxygen levels. If you are looking to maximize blastocyst yield, having a candid conversation with your clinic about their culture environment and oxygen strategy is likely more productive than adding a supplement.

1
Human Reproduction. Cleavage stage versus blastocyst stage transfers in patients with a single zygote: an emulated target trial
2
BIO Web of Conferences. Comparison of fertilization, blastocyst, pregnancy and implantation rates between PCOS and non-PCOS women undergoing IVF/ICSI cycles
3
PubMed. Sculpting the Transcriptome During the Oocyte-to-Embryo Transition in Mouse
4
PubMed Central. Unraveling the mysteries of early embryonic arrest: genetic factors and molecular mechanisms
5
PubMed. Maternal age effect on early human embryonic development and blastocyst formation
6
PubMed. Influence of advanced age on the blastocyst development rate and pregnancy rate in assisted reproductive technology
7
PubMed Central. Effect of sperm DNA fragmentation on embryo development: clinical and biological aspects
8
PubMed Central. Sperm DNA Fragmentation Impairs Early Embryo Development but Is Not Predictive of Pregnancy Outcomes: Insights from 870 ICSI Cycles
9
PubMed. What sperm parameters effect blastocyst formation and quality during ICSI with severe male infertility
10
PubMed. Low-oxygen compared with high-oxygen atmosphere in blastocyst culture, a prospective randomized study
11
Scientific Reports. Biphasic (5–2%) oxygen concentration strategy significantly improves the usable blastocyst and cumulative live birth rates in in vitro fertilization
12
PubMed Central. Single versus sequential culture medium: which is better at improving ongoing pregnancy rates? A systematic review and meta-analysis
13
PubMed Central. Comparison of two commercial embryo culture media (SAGE-1 step single medium vs. G1-PLUS™/G2-PLUS™ sequential media): Influence on in vitro fertilization outcomes and human embryo quality
14
PubMed Central. Comparison of Embryo and Egg Quality in Polycystic Ovary Syndrome Patients Having Regular vs Irregular Menstrual Patterns
15
PubMed. Diminished ovarian reserve is associated with reduced euploid rates via preimplantation genetic testing for aneuploidy independently from age: evidence for concomitant reduction in oocyte quality with quantity
16
Fertility Science and Research. From Oocyte to Blastocyst: A Comparison of IVF Embryo Attrition Rates Based on Ovarian Reserve
17
PubMed Central. The Morphology of Inner Cell Mass Is the Strongest Predictor of Live Birth After a Frozen-Thawed Single Embryo Transfer
18
PubMed Central. Effect of Blastocyst Morphology and Developmental Rate on Euploidy and Live Birth Rates in PGT-A Cycles: A Retrospective Cohort Study
19
PubMed. Total duration of spontaneous blastocyst collapse during the expansion stage is an independent predictor of euploidy and live birth rates
20
PubMed Central. Cleavage‐stage versus blastocyst‐stage embryo transfer in assisted reproductive technology
21
PubMed Central. Effects of controlled ovarian stimulation regimens on top-quality blastocyst development and perinatal outcomes with the freeze-all strategy: A retrospective comparative study
22
PubMed Central. Artificial intelligence system for outcome evaluations of human in vitro fertilization-derived embryos
23
Human Reproduction. L26/P-227 Comparative analysis of a Key Performance Indicator (KPI) score and artificial intelligence for predicting blastocyst implantation and subsequent live births
24
PubMed Central. Time-lapse technology for embryo culture and selection
25
North American Proceedings in Gynecology and Obstetrics – Supplemental. IMPACT OF HUMAN GROWTH HORMONE ON IVF OUTCOMES IN PATIENTS WITH DIMINISHED OVARIAN RESERVE